These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 2538045)

  • 1. The postpartum Papanicolaou smear.
    Weiss BD; Senf JH; Udall W
    J Am Board Fam Pract; 1989; 2(1):4-9. PubMed ID: 2538045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cytologic cancer prevention with smears of the uterine cervix and endocervical canal in pregnancy].
    Torsten U; Opri F; Weitzel H
    Gynakol Geburtshilfliche Rundsch; 1992; 32(1):40-2. PubMed ID: 1515780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antepartum and postpartum Papanicolaou smears. Are they both necessary?
    Jazayeri A; Heffron JA; Harnetty P; Jazayeri M; Gould SF
    J Reprod Med; 1999 Oct; 44(10):879-82. PubMed ID: 10554750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital.
    Lertcharernrit J; Sananpanichkul P; Suknikhom W; Bhamarapravatana K; Suwannarurk K; Leaungsomnapa Y
    Asian Pac J Cancer Prev; 2016; 17(8):4163-7. PubMed ID: 27644678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for human papillomavirus in women with abnormal pap smear results.
    McCaffery KJ; Waller J; Forrest S; Wardle J
    JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of the mildly abnormal Pap smear: a conservative approach.
    Brown MS; Phillips GL
    Gynecol Oncol; 1985 Oct; 22(2):149-53. PubMed ID: 2996992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of abnormal cervical pap smear undertaken during pregnancy to the outcome of the pregnancy.
    Qi L; Wang S; Liang J; Zhang Z; Lu H
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jul; 37(7):388-90. PubMed ID: 12411032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening in an urban emergency department.
    Hogness CG; Engelstad LP; Linck LM; Schorr KA
    Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
    Adam Y; McIntyre JA; De Bruyn G
    S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of the postpartum Papanicolaou smear.
    Rarick TL; Tchabo JG
    Obstet Gynecol; 1994 May; 83(5 Pt 1):761-5. PubMed ID: 8164940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
    Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence and course of preinvasive cervical lesions during pregnancy in a Northern Nigerian Teaching Hospital.
    Bakari F; Abdul MA; Ahmed SA
    Ann Afr Med; 2017; 16(2):74-80. PubMed ID: 28469121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
    Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
    S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal and postpartum Pap smears: do we need both?
    Londo R; Bjelland T; Girod C; Glasser M
    Fam Pract Res J; 1994 Dec; 14(4):359-67. PubMed ID: 7863808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cytology in vulnerable pregnant women.
    Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
    J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal Papanicolaou smear. A population-based study of risk factors in Greenlandic and Danish women.
    Kjaer SK; Poll P; Jensen H; Engholm G; Haugaard BJ; Teisen C; Christensen RB; Möller KA; Vestergaard BF; de Villiers EM
    Acta Obstet Gynecol Scand; 1990; 69(1):79-86. PubMed ID: 2161172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
    Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.